The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …

Individuals with compromised immune systems, whether because of immunodeficiency or
immuno suppressive therapy, are among those most susceptible to COVID19. In fact, people …

Approximately 3% of US adults are immunocompromised and less capable of fighting
infections such as SARS-CoV-2 (the causative agent of COVID-19). Individuals may be …

Background WHO has established a Global Clinical Platform for the clinical characterisation
of COVID-19 among hospitalised individuals. We assessed whether people living with HIV …

Importance Recommendations for additional doses of COVID-19 vaccines for people with
HIV (PWH) are restricted to those with advanced disease or unsuppressed HIV viral load …

This review examines the intersection of the HIV and SARS-CoV-2 pandemics. People with
HIV (PWH) are a heterogeneous group that differ in their degree of immune suppression …

The clinical implications of COVID-19 have changed since SARS-CoV-2 first emerged in
humans. The current high levels of population immunity, due to prior infection and/or …

Abstract Purpose of Review In this review, we examine the intersection of the HIV and
COVID-19 epidemics with focus on COVID-19-related health outcomes and risk factors for …

Importance Understanding the severity of postvaccination SARS-CoV-2 (ie, COVID-19)
breakthrough illness among people with HIV (PWH) can inform vaccine guidelines and risk …

The administration of COVID-19 vaccines is the primary strategy used to prevent further
infections by COVID-19, especially in people living with HIV (PLWH), who are at increased …